期刊文献+

卵巢恶性中胚叶混合瘤临床病理分析

下载PDF
导出
摘要 目的探讨原发于卵巢的恶性中胚叶混合瘤(malignant mesodermal mixed tumor,MMMT)的临床表现及病理组织学特点。方法总结观察5例原发于卵巢的MMMT病例的病理学特点,结合临床资料进行分析。结果 5例MMMT临床症状均表现腹胀伴轻微腹痛,并出现盆腔肿块及阴道不规则出血,病理特点为恶性上皮及恶性间叶成分并存,即癌与肉瘤成分混合存在,癌性成分以子宫内膜样癌及浆液性腺癌为主,肉瘤成分以软骨肉瘤及平子宫内膜间质肉瘤为主。结论 MMMT为一种高度侵袭性恶性肿瘤,肿瘤病人的预后与癌性成分有关,而与肉瘤成分无关[1]。
出处 《河北医药》 CAS 2014年第15期2265-2267,共3页 Hebei Medical Journal
  • 相关文献

参考文献13

  • 1Meis JM, Iawernce WD. 1990 The immunohistochemical profile of malig- nant mixed Mullerian tumor :overlap with endometrial adenocarcinoma. Am J Clin Pathol, 1990,94 : 1-7.
  • 2Clement PB, Scully RE. Extrauterine mesodermal (mullerian) adenosarco- mas:A elinieopathologie analysis of five eases. Am J Clin Pathol, 1978, 69:276-283.
  • 3Marchevsky AM, Kaneko M. Bilateral ovarian endometriosis associated of the right ovary and endometrioid carcinoma of the left ovary. Am J Clin Pathol, 1978,70:709.
  • 4Imaehi M,Tsukamoto N, Shigematsu T,et al. Malignant mixed n mulleri- an tumor of the fallopian tube : report of two cases and review of litera- ture. Gynecologic Ontology,1992,47: 114-124.
  • 5Garde JR,Jones MA, McAfee R, et al. Extragenital malignant mixedmul- lerian tumor: review of the literature Gynecologic Oneology, 1991,43 : 186-190.
  • 6Nimaroff M, Gal D, Susin M, et al. Extragenital malignant mixed mullerian tumor. European Journal of Gynaecologiel Oncology, 1993,14:23-27.
  • 7Mostoufizadeh M, Scully RE. Malignant tumors arising in endometriosis. Clin Obstct Gynecol, 1980,23:951-963.
  • 8SternbergS主编.回允中译.诊断外科病理学.第3版.北京:北京大学医学出版社,2003.2333.
  • 9刘海元,沈铿,郎景和,向阳,王友芳,连利娟,吴鸣,黄惠芳,潘凌亚.女性生殖系统恶性中胚叶混合瘤13例临床分析[J].癌症进展,2003,1(2):148-152. 被引量:4
  • 10Hernandez W, DiSaia PJ, Morrow CP, et al. Mixed mosodermal sarcoma of the ovary. Obstet Gynecol, 1977,49:595-635.

二级参考文献10

  • 1白萍,孙建衡,晁红霞,仇铁珍.子宫肉瘤153例临床分析[J].中华妇产科杂志,1997,32(3):163-167. 被引量:27
  • 2[1]Philip BC, Judit TZ, Robert HY, et al. Malignant mullerian mixed tumor of the uterinecervix: A report of nine case of a neoplasm with morphology often different from its counterpart in the corpus. Inte J Gyne Path, 1998, 17:211~221
  • 3[2]Iwasa Y, Hega H, Konish I, et al. Prognostic factors in uterine carcinosarcoma: A pathologic study of 25 patients. Cancer, 1998, 82:512~519
  • 4[3]Ebert AD, Perez-Canto A, Schaller G, et al. Stage Ⅰ primary mixed mullerian tumor of the fallopian tube: Report of a case with five-year survival after minimal surgery without adjuvant treatment. J Reproductive Medicine, 1998, 43: 598 ~ 600
  • 5[4]Munts HG, Jones MA, Goff BA, et al. Malignant mixed mullerian tumor of the ovary: Experience with surgical cytoreduction and combination chemotherapy. Cancer, 1995, 76:1209~ 1213
  • 6[5]Guarinom, Giordanof, Palizzotti G, et al. Malignant mixed mullerian tumor of the uterus features favoring its origin from a common cell clone and an epithelial - to - mesenchymal transformation mechanism of histogenesis. Tumor 1998, 84:391 ~ 397
  • 7[7]Sutton GP, Blessing JA, Barrett R J, et al. Phase Ⅱ trial of ifosamide and mesna in leiomysarcoma of the uterus: A Gynecological Oncology Group Study. AmJ Obstet Gynecol, 1992, 166:556~559
  • 8[9]Linda, RD, Audrey G, Ganul H, et al. Pacitaxel and platium chemotherapy for MMMTs of the ovary. Gynecol Oncol, 2002, 85:459~463
  • 9[11]Anil KS, Jool IS, Mark SG, et al. Primary ovarian sarcoma. Cancer,1998, 82 (9) :1731~1737
  • 10李洪君,石素胜,章文华.卵巢恶性中胚叶混合瘤12例临床分析[J].中华肿瘤杂志,1998,20(6):460-462. 被引量:10

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部